Sleepiz AG


Medical technology company developing contactless, bedside radar devices and cloud software to monitor sleep and vital signs at home. Provides AI-driven analytics and data capture for remote patient monitoring, clinical research, and consumer device integration. Holds European medical device certification and security/privacy certifications and has published clinical validation versus polysomnography.

Industries

health-care
medical
medical-device

Nr. of Employees

medium (51-250)


Products

Contactless bedside radar monitoring device

Non-wearable bedside radar device for home use that measures respiration, pulse-related micro-movements, body motion and derives sleep parameters; designed for plug-and-play setup and automatic data upload.


Services

Deployment of bedside contactless radar sensing hardware and cloud monitoring for continuous at-home capture of sleep and vital-sign metrics, with clinician access via web interface.

Provision of validated sleep and respiratory endpoints via device deployments and API integrations for clinical studies and pharmaceutical trials.

Cloud-based AI analytics that can be integrated into devices containing radar chips to provide vital-sign and sleep metrics via APIs.

Expertise Areas

  • Remote patient monitoring
  • Home sleep testing and sleep disorder screening
  • Clinical trial data collection and digital endpoints
  • Radar-based contactless vital sign monitoring
  • Show More (3)

Key Technologies

  • Millimeter-wave radar sensing (24 GHz)
  • Contactless vital-sign detection
  • Digital signal processing
  • Machine learning for sleep analytics
  • Show More (4)

News & Updates

Strategic partnership to integrate contactless sleep and respiratory endpoints into clinical trials via cloud integration for longitudinal data.

Company registered its contactless respiration and heart rate monitoring device with U.S. FDA to enable remote patient monitoring and clinical-study use in the U.S.

Information security (ISO 27001) and privacy information management (ISO 27701) certifications obtained following independent audits.

Peer-reviewed clinical studies validating contactless respiration and sleep-apnea diagnosis against polysomnography (multiple PubMed-indexed publications).

Completed Series A financing second close bringing total investment to CHF 6.2 million to support market launch and expansion.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.